HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

ovcon 35

a chewable oral contraceptive

Networked: 4 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Experts

1.	Grinspoon, Steven: 3 articles (08/2004 - 06/2002)
2.	Klibanski, Anne: 3 articles (08/2004 - 06/2002)
3.	Herzog, David: 2 articles (03/2003 - 06/2002)
4.	Miller, Karen: 2 articles (03/2003 - 06/2002)
5.	Grieco, Kelly A: 1 article (08/2004)
6.	Herzog, David B: 1 article (08/2004)
7.	Miller, Karen K: 1 article (08/2004)
8.	Clemmons, David: 1 article (03/2003)
9.	Thomas, Lisa: 1 article (06/2002)

Related Diseases

1.	Anorexia Nervosa 03/01/2003 - "Sixty-five osteopenic women with anorexia nervosa were randomized to rhIGF-I (30 micro g/kg sc twice daily) alone (n = 15), daily ethinyl estradiol (Ovcon 35) with rhIGF-I (n = 15), estradiol and placebo (n = 15), or placebo (n = 14) for 9 months. " 06/01/2002 - "Sixty osteopenic women with Diagnosis and Statistical Manual of Mental Disorders IV Revised confirmed anorexia nervosa [age (25.2 +/- 0.7 yr, range 18-38 yr), body mass index (17.8 +/- 0.3 kg/m(2) ), spinal bone mineral density T score (-2.1 +/- 0.1 SD) were randomized to one of four treatment groups [rhIGF-I (30 microg/kg sc twice daily) and a daily oral contraceptive (Ovcon 35, 35 microg ethinyl estradiol and 0.4 mg norethindrone], rhIGF-I alone (30 microg/kg sc twice daily), oral contraceptive alone, or neither treatment for 9 months. " 08/01/2004 - "We investigated the effects of sex steroids and IGF-I on ghrelin in 78 female subjects with anorexia nervosa simultaneously randomized to receive estrogen (Ovcon 35, 35 microg ethinyl estradiol, and 0.4 mg norethindrone) as well as recombinant human (rh)IGF-I (30 microg/kg sc twice a day) in a two-by-two factorial model, in which the individual effects of estrogen (E) and rhIGF-I on ghrelin could be determined. "
2.	Gestational Diabetes (Gestational Diabetes Mellitus) 01/01/1991 - " The author compared a low-dose combined pill with 400 mcg norethindrone and 35 mcg ethinyl estradiol (Ovcon 35), and a pill containing levonorgestrel (Triphasil), to barrier contraception in 230 women with recent gestational diabetes. "
3.	Mental Disorders (Mental Disorder) 06/01/2002 - "Sixty osteopenic women with Diagnosis and Statistical Manual of Mental Disorders IV Revised confirmed anorexia nervosa [age (25.2 +/- 0.7 yr, range 18-38 yr), body mass index (17.8 +/- 0.3 kg/m(2) ), spinal bone mineral density T score (-2.1 +/- 0.1 SD) were randomized to one of four treatment groups [rhIGF-I (30 microg/kg sc twice daily) and a daily oral contraceptive (Ovcon 35, 35 microg ethinyl estradiol and 0.4 mg norethindrone], rhIGF-I alone (30 microg/kg sc twice daily), oral contraceptive alone, or neither treatment for 9 months. "

Related Drugs and Biologics

1.	Ethinyl Estradiol (Estinyl)
2.	Norethindrone (Norethisterone)
3.	Ghrelin
4.	Ethinyl Estradiol-Norgestrel Combination (Ovral)
5.	Levonorgestrel (Plan B)
6.	Steroids
7.	Insulin-Like Growth Factor I (IGF-1)
8.	Estrogens (Estrogen)
9.	Estradiol (Delestrogen)
10.	Oral Contraceptives

Related Therapies and Procedures

1.	Barrier Contraception